CIK 0001783875
FFNTF 4Front Ventures Corp.
Insider trading from SEC Form 4. Last filing May 19, 2025.
In brief
4Front Ventures Corp. (FFNTF) has 17 SEC Form 4 filings on file from 8 insiders, the latest filed on May 19, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at 4Front Ventures Corp., scored.
Transactions
Every row filed, 41 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 11, 2025 | Kristopher Krane President, Advocacy | AGrant or award Class A Subordinate Voting Shares | +1,792,768 | $0.04 | $72k | 2,204,038 | Apr 22, 2025 |
| Apr 11, 2025 | David Ryan Daily director | AGrant or award Class A Subordinate Voting Shares | +1,792,768 | $0.04 | $72k | 2,204,038 | Apr 22, 2025 |
| Jan 10, 2025 | Michael Kronberg Chief Financial Officer | AGrant or award Option to purchase SVSderivative | +150,000 | - | - | 150,000 | Feb 12, 2025 |
| Jan 10, 2025 | Michael Kronberg Chief Financial Officer | DDisposition to issuer Option to purchase SVSderivative | -150,000 | - | - | 0 | Feb 12, 2025 |
| Jan 3, 2025 | Roman Tkachenko director | AGrant or award Stock Option (right to buy)derivative | +400,000 | - | - | 2,200,000 | Jan 6, 2025 |
| Jan 3, 2025 | Roman Tkachenko director | DDisposition to issuer Stock Option (right to buy)derivative | -400,000 | - | - | 0 | Jan 6, 2025 |
| Jan 3, 2025 | Roman Tkachenko director | AGrant or award Stock Option (right to buy)derivative | +1,100,000 | - | - | 2,200,000 | Jan 6, 2025 |
| Jan 3, 2025 | Roman Tkachenko director | DDisposition to issuer Stock Option (right to buy)derivative | -1,100,000 | - | - | 0 | Jan 6, 2025 |
| Jan 3, 2025 | Roman Tkachenko director | AGrant or award Stock Option (right to buy)derivative | +700,000 | - | - | 2,200,000 | Jan 6, 2025 |
| Jan 3, 2025 | Roman Tkachenko director | DDisposition to issuer Stock Option (right to buy)derivative | -700,000 | - | - | 0 | Jan 6, 2025 |
| Dec 23, 2024 | Leonid Gontmakher director | AGrant or award Stock Option (right to buy)derivative | +400,000 | - | - | 4,100,000 | Dec 26, 2024 |
| Dec 23, 2024 | Leonid Gontmakher director | DDisposition to issuer Stock Option (right to buy)derivative | -400,000 | - | - | 0 | Dec 26, 2024 |
| Dec 23, 2024 | Leonid Gontmakher director | AGrant or award Stock Option (right to buy)derivative | +3,700,000 | - | - | 4,100,000 | Dec 26, 2024 |
| Dec 23, 2024 | Leonid Gontmakher director | DDisposition to issuer Stock Option (right to buy)derivative | -3,700,000 | - | - | 0 | Dec 26, 2024 |
| Dec 20, 2024 | David Ryan Daily director | AGrant or award Stock Option (right to buy)derivative | +400,000 | - | - | 1,600,000 | Dec 23, 2024 |
| Dec 20, 2024 | Chetan Gulati director | AGrant or award Stock Option (right to buy)derivative | +400,000 | - | - | 1,950,000 | Dec 23, 2024 |
| Dec 20, 2024 | David Ryan Daily director | DDisposition to issuer Stock Option (right to buy)derivative | -400,000 | - | - | 0 | Dec 23, 2024 |
| Dec 20, 2024 | Chetan Gulati director | DDisposition to issuer Stock Option (right to buy)derivative | -400,000 | - | - | 0 | Dec 23, 2024 |
| Dec 20, 2024 | Chetan Gulati director | AGrant or award Stock Option (right to buy)derivative | +1,550,000 | - | - | 1,950,000 | Dec 23, 2024 |
| Dec 20, 2024 | David Ryan Daily director | AGrant or award Stock Option (right to buy)derivative | +1,200,000 | - | - | 1,600,000 | Dec 23, 2024 |
| Dec 20, 2024 | Chetan Gulati director | DDisposition to issuer Stock Option (right to buy)derivative | -1,550,000 | - | - | 0 | Dec 23, 2024 |
| Dec 20, 2024 | David Ryan Daily director | DDisposition to issuer Stock Option (right to buy)derivative | -1,200,000 | - | - | 0 | Dec 23, 2024 |
| Dec 16, 2024 | Kristopher Krane President, Advocacy | AGrant or award Stock Option (right to buy)derivative | +400,000 | - | - | 4,729,840 | Dec 18, 2024 |
| Dec 16, 2024 | Andrew Thut Chief Executive Officer | AGrant or award Stock Option (right to buy)derivative | +8,045,600 | - | - | 14,011,040 | Dec 18, 2024 |
| Dec 16, 2024 | Karl Chowscano other | AGrant or award Stock Option (right to buy)derivativeindirect: Philomena Investments, LLC | +5,303,200 | - | - | 10,303,200 | Dec 18, 2024 |
| Dec 16, 2024 | Karl Chowscano other | DDisposition to issuer Stock Option (right to buy)derivativeindirect: Philomena Investments, LLC | -5,303,200 | - | - | 0 | Dec 18, 2024 |
| Dec 16, 2024 | Andrew Thut Chief Executive Officer | DDisposition to issuer Stock Option (right to buy)derivative | -8,045,600 | - | - | 0 | Dec 18, 2024 |
| Dec 16, 2024 | Kristopher Krane President, Advocacy | DDisposition to issuer Stock Option (right to buy)derivative | -400,000 | - | - | 0 | Dec 18, 2024 |
| Dec 16, 2024 | Karl Chowscano other | AGrant or award Stock Option (right to buy)derivativeindirect: Philomena Investments, LLC | +5,000,000 | - | - | 10,303,200 | Dec 18, 2024 |
| Dec 16, 2024 | Kristopher Krane President, Advocacy | AGrant or award Stock Option (right to buy)derivative | +600,000 | - | - | 4,729,840 | Dec 18, 2024 |
| Dec 16, 2024 | Andrew Thut Chief Executive Officer | AGrant or award Stock Option (right to buy)derivative | +4,000,000 | - | - | 14,011,040 | Dec 18, 2024 |
| Dec 16, 2024 | Kristopher Krane President, Advocacy | DDisposition to issuer Stock Option (right to buy)derivative | -600,000 | - | - | 0 | Dec 18, 2024 |
| Dec 16, 2024 | Karl Chowscano other | DDisposition to issuer Stock Option (right to buy)derivativeindirect: Philomena Investments, LLC | -5,000,000 | - | - | 0 | Dec 18, 2024 |
| Dec 16, 2024 | Andrew Thut Chief Executive Officer | DDisposition to issuer Stock Option (right to buy)derivative | -4,000,000 | - | - | 0 | Dec 18, 2024 |
| Dec 16, 2024 | Kristopher Krane President, Advocacy | AGrant or award Stock Option (right to buy)derivative | +1,000,000 | - | - | 4,729,840 | Dec 18, 2024 |
| Dec 16, 2024 | Andrew Thut Chief Executive Officer | AGrant or award Stock Option (right to buy)derivative | +1,965,440 | $0.00 | $0 | 14,011,040 | Dec 18, 2024 |
| Dec 16, 2024 | Kristopher Krane President, Advocacy | DDisposition to issuer Stock Option (right to buy)derivative | -1,000,000 | - | - | 0 | Dec 18, 2024 |
| Dec 16, 2024 | Kristopher Krane President, Advocacy | AGrant or award Stock Option (right to buy)derivative | +2,729,840 | $0.00 | $0 | 4,729,840 | Dec 18, 2024 |
| Aug 4, 2023 | Karl Chowscano other | AGrant or award Class A Subordinate Voting Sharesindirect: By Philomena Investments, LLC | +2,806,788 | $0.00 | $0 | 17,924,148 | Nov 9, 2023 |
| Aug 4, 2023 | Andrew Thut Chief Investment Officer | AGrant or award Class A Subordinate Voting Shares | +2,405,818 | $0.00 | $0 | 14,084,778 | Nov 9, 2023 |
| Oct 19, 2023 | Chetan Gulati director | JOther Convertible Promissory Notesderivativeindirect: See footnotes | +46,086,956 | $0.23 | $11M | 48,194,267 | Oct 30, 2023 |
Insiders
Everyone who has filed a Form 4 here.
- Karl Chowscanoother
- David Ryan Dailydirector
- Leonid Gontmakherdirector
- Chetan Gulatidirector
- Kristopher KranePresident, Advocacy
- Michael KronbergSee Remarks
- Andrew ThutChief Investment Officer
- Roman Tkachenkodirector
Questions about FFNTF
Answered from the filings on this page, as of the latest one.
Are insiders buying FFNTF?
No. In the last 90 days no insider at 4Front Ventures Corp. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade FFNTF on the open market?
No open-market trade has been scored at 4Front Ventures Corp.. The latest Form 4 on file was filed on May 19, 2025 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at 4Front Ventures Corp.?
8 people have filed a Form 4 at 4Front Ventures Corp., among them Karl Chowscano (insider), David Ryan Daily (director), Leonid Gontmakher (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.